NCT00000373View on ClinicalTrials.gov

Treatment of Obsessive-Compulsive Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

September 30, 1992

Primary Completion Date

January 31, 2003

Study Completion Date

July 31, 2003

Conditions
Obsessive-Compulsive Disorder
Interventions
DRUG

olanzapine + fluoxetine

DRUG

placebo + fluoxetine

Trial Locations (2)

32257

University of Florida Behavioral Health Mandarin Clinic, Jacksonville

32608

Psychiatric Specialty Clinic, Shands Hospital at the University of Florida, Gainesville

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Florida

OTHER

NCT00000373 - Treatment of Obsessive-Compulsive Disorder | Biotech Hunter | Biotech Hunter